Pasar al contenido principal

REMODELADO DE OLIGOMEROS Y FIBRAS DE PROTEINAS RELACIONADAS CON NEURODEGENERACION POR MAQUINARIA DE DESAGREGACION BASADA EN HSP70 HUMANA

PID2019-111068GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DEL PAIS VASCO EUSKAL HERRIKO UNIBERTSITATEA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The self-association equilibrium of DNAJA2 regulates its interaction with unfolded substrate proteins and with Hsc70

  • Velasco-Carneros, Lorea|||0000-0002-1296-9498
  • Cuéllar, Jorge|||0000-0002-7789-807X
  • Dublang, Leire
  • Santiago, César|||0000-0002-5149-1722
  • Maréchal, Jean-Didier|||0000-0002-8344-9043
  • Martín-Benito, Jaime|||0000-0002-8541-4709
  • Maestro, Moisés|||0000-0002-7955-9135
  • Fernández-Higuero, José Ángel
  • Orozco, Natalia
  • Moro, Fernando
  • Valpuesta, Jose María|||0000-0001-7468-8053
  • Muga, Arturo|||0000-0003-0345-6882
J-domain proteins tune the specificity of Hsp70s, engaging them in precise functions. Despite their essential role, the structure and function of many J-domain proteins remain largely unknown. We explore human DNAJA2, finding that it reversibly forms highly-ordered, tubular structures that can be dissociated by Hsc70, the constitutively expressed Hsp70 isoform. Cryoelectron microscopy and mutational studies reveal that different domains are involved in self-association. Oligomer dissociation into dimers potentiates its interaction with unfolded client proteins. The J-domains are accessible to Hsc70 within the tubular structure. They allow binding of closely spaced Hsc70 molecules that could be transferred to the unfolded substrate for its cooperative remodelling, explaining the efficient recovery of DNAJA2-bound clients. The disordered C-terminal domain, comprising the last 52 residues, regulates its holding activity and productive interaction with Hsc70. These in vitro findings suggest that the association equilibrium of DNAJA2 could regulate its interaction with client proteins and Hsc70. J-domain proteins (JDPs) regulate Hsp70 function and specificity. Here, authors combine functional assays and cryoEM to describe the structure of a dynamic tubular assembly of DNAJA2, a class A JDP, and its stabilizing interdomain interactions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Pseudophosphorylation of single residues of the J-domain of regulates the holding/folding balance of the Hsc70 system

  • Velasco-Carneros, Lorea|||0000-0002-1296-9498
  • Bernardo-Seisdedos, Ganeko
  • Maréchal, Jean-Didier|||0000-0002-8344-9043
  • Millet, Oscar
  • Moro, Fernando
  • Muga, Arturo|||0000-0003-0345-6882
The Hsp70 system is essential for maintaining protein homeostasis and comprises a central Hsp70 and two accessory proteins that belong to the J-domain protein (JDP) and nucleotide exchange factor families. Posttranslational modifications offer a means to tune the activity of the system. We explore how phosphorylation of specific residues of the J-domain of DNAJA2, a class A JDP, regulates Hsc70 activity using biochemical and structural approaches. Among these residues, we find that pseudophosphorylation of Y10 and S51 enhances the holding/folding balance of the Hsp70 system, reducing cochaperone collaboration with Hsc70 while maintaining the holding capacity. Truly phosphorylated J domains corroborate phosphomimetic variant effects. Notably, distinct mechanisms underlie functional impacts of these DNAJA2 variants. Pseudophosphorylation of Y10 induces partial disordering of the J domain, whereas the S51E substitution weakens essential DNAJA2-Hsc70 interactions without a large structural reorganization of the protein. S51 phosphorylation might be class-specific, as all cytosolic class A human JDPs harbor a phosphorylatable residue at this position.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fine-tuning of the Hsc70-based Human Protein Disaggregase Machinery by the Distinctive C-terminal Extension of Apg2

  • Cabrera, Yovana
  • Bernardo-Seisdedos, Ganeko
  • Dublang, Leire
  • Albesa-Jové, David
  • Orozco, Natalia
  • Viguera, Ana Rosa
  • Millet, Óscar
  • Muga, Arturo
  • Moro, Fernando
Apg2, one of the three cytosolic Hsp110 chaperones in humans, supports reactivation of unordered and ordered protein aggregates by Hsc70 (HspA8). Together with DnaJB1, Apg2 serves to nucleate Hsc70 molecules into sites where productive entropic pulling forces can be developed. During aggregate reactivation, Apg2 performs as a specialized nucleotide exchange factor, but the origin of its specialization is poorly defined. Here we report on the role of the distinctive C-terminal extension present in Apg2 and other metazoan homologs. We found that the first part of this Apg2 subdomain, with propensity to adopt α-helical structure, interacts with the nucleotide binding domain of Hsc70 in a nucleotide-dependent manner, contributing significantly to the stability of the Hsc70:Apg2 complex. Moreover, the second intrinsically disordered segment of Apg2 C-terminal extension plays an important role as a downregulator of nucleotide exchange. An NMR analysis showed that the interaction with Hsc70 nucleotide binding domain modifies the chemical environment of residues located in important functional sites such as the interface between lobe I and II and the nucleotide binding site. Our data indicate that Apg2 C-terminal extension is a fine-tuner of human Hsc70 activity that optimizes the substrate remodeling ability of the chaperone system., .C. and L.D. were recipients of UPV/EHU and MEC FPU predoctoral fellowships, respectively. We thank Fundación Biofisika Bizkaia for supporting N.O. This work was supported by CTQ2016-76941-R (MINECO), Fundación Biofísica Bizkaia, the Basque Excellence Research Centre (BERC) of the Basque Government and Fundación BBVA to D.A.-J., and BFU2016-75983-P and PID2019-111068 GB-100 (MCI/AEI/FEDER, UE) grants from Spanish Government to A.M. and F.M. and IT1745-22 from Basque Government to F.M., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies

  • Morten, Michael J.
  • Sirvio, Liina
  • Rupawala, Huzefa
  • Mee Hayes, Emma
  • Franco, Aitor
  • Radulescu, Carola
  • Ying, Liming
  • Barnes, Samuel J.
  • Muga, Arturo
  • Ye, Yu
Protein aggregation is a hallmark of major neurodegenerative disorders. Increasing data suggest that smaller aggregates cause higher toxic response than filamentous aggregates (fibrils). However, the size of small aggregates has challenged their detection within biologically relevant environments. Here, we report approaches to quantitatively super-resolve aggregates in live cells and ex vivo brain tissues. We show that Amytracker 630 (AT630), a commercial aggregate-activated fluorophore, has outstanding photophysical properties that enable super-resolution imaging of α-synuclein, tau, and amyloid-β aggregates, achieving ∼4 nm precision. Applying AT630 to AppNL-G-F mouse brain tissues or aggregates extracted from a Parkinson's disease donor, we demonstrate excellent agreement with antibodies specific for amyloid-β or α-synuclein, respectively, confirming the specificity of AT630. Subsequently, we use AT630 to reveal a linear relationship between α-synuclein aggregate size and cellular toxicity and discovered that aggregates smaller than 450 ± 60 nm (aggregate450nm) readily penetrated the plasma membrane. We determine aggregate450nm concentrations in six Parkinson's disease and dementia with Lewy bodies donor samples and show that aggregates in different synucleinopathies demonstrate distinct potency in toxicity. We further show that cell-penetrating aggregates are surrounded by proteasomes, which assemble into foci to gradually process aggregates. Our results suggest that the plasma membrane effectively filters out fibrils but is vulnerable to penetration by aggregates of 450 ± 60 nm. Together, our findings present an exciting strategy to determine specificity of aggregate toxicity within heterogeneous samples. Our approach to quantitatively measure these toxic aggregates in biological environments opens possibilities to molecular examinations of disease mechanisms under physiological conditions., Research in the Y.Y. lab is supported by a UK Dementia Research Institute Fellowship [UKDRI-5009] awarded to Y.Y. UK Dementia Research Institute receives its funding from UK DRI Ltd, funded by the UK Medical Research Council, Alzheimer’s Society, and Alzheimer’s Research UK. This work, including cell lines generated, was funded by a Sir Henry Wellcome Research Fellowship [101585/Z/13/Z] awarded to Y.Y. A.M. thanks Agencia Estatal de Investigación - Fondo Europeo de Desarrollo Regional (AEI-FEDER Grant number PID2019-111068GB-I00) and Basque Government (Grant number IT-1745-22) for funding., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Inhibition of the Human Hsc70 System by Small Ligands as a Potential Anticancer Approach

  • Dublang, Leire
  • Underhaug, Jarl
  • Flydal, Marte I.
  • Velasco-Carneros, Lorea
  • Maréchal, Jean Didier
  • Moro, Fernando
  • Boyano, María Dolores
  • Martínez, Aurora
  • Muga, Arturo
Heat shock protein (Hsp) synthesis is upregulated in a wide range of cancers to provide the appropriate environment for tumor progression. The Hsp110 and Hsp70 families have been associated to cancer cell survival and resistance to chemotherapy. In this study, we explore the strategy of drug repurposing to find new Hsp70 and Hsp110 inhibitors that display toxicity against melanoma cancer cells. We found that the hits discovered using Apg2, a human representative of the Hsp110 family, as the initial target bind also to structural regions present in members of the Hsp70 family, and therefore inhibit the remodeling activity of the Hsp70 system. One of these compounds, the spasmolytic agent pinaverium bromide used for functional gastrointestinal disorders, inhibits the intracellular chaperone activity of the Hsp70 system and elicits its cytotoxic activity specifically in two melanoma cell lines by activating apoptosis. Docking and molecular dynamics simulations indicate that this compound interacts with regions located in the nucleotide-binding domain and the linker of the chaperones, modulating their ATPase activity. Thus, repurposing of pinaverium bromide for cancer treatment appears as a promising novel therapeutic approach., This study was funded by grants BFU2016-75983-P and PID2019-111068GB-100 (AEI/FEDER/UE) from MINECO to F.M. and A.M. (Arturo Muga) and IT1201-19 from the Basque Government to F.M. Support from the Research Council of Norway (RCN, Grant FRIMEDBIO 261826/F20), the Western Norway Regional Health Authority (912246 to A.M. (Aurora Martinez) and M.I.F.), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Truncation-Driven Lateral Association of α-Synuclein Hinders Amyloid Clearance by the Hsp70-Based Disaggregase

  • Franco, Aitor
  • Cuéllar, Jorge
  • Fernández-Higuero, José Ángel
  • Arada, Igor de la
  • Orozco, Natalia
  • Valpuesta, José M.
  • Prado, Adelina
  • Muga, Arturo
The aggregation of α-synuclein is the hallmark of a collective of neurodegenerative disorders known as synucleinopathies. The tendency to aggregate of this protein, the toxicity of its aggregation intermediates and the ability of the cellular protein quality control system to clear these intermediates seems to be regulated, among other factors, by post-translational modifications (PTMs). Among these modifications, we consider herein proteolysis at both the N- and C-terminal regions of α-synuclein as a factor that could modulate disassembly of toxic amyloids by the human disaggregase, a combination of the chaperones Hsc70, DnaJB1 and Apg2. We find that, in contrast to aggregates of the protein lacking the N-terminus, which can be solubilized as efficiently as those of the WT protein, the deletion of the C-terminal domain, either in a recombinant context or as a consequence of calpain treatment, impaired Hsc70-mediated amyloid disassembly. Progressive removal of the negative charges at the C-terminal region induces lateral association of fibrils and type B* oligomers, precluding chaperone action. We propose that truncation-driven aggregate clumping impairs the mechanical action of chaperones, which includes fast protofilament unzipping coupled to depolymerization. Inhibition of the chaperone-mediated clearance of C-truncated species could explain their exacerbated toxicity and higher propensity to deposit found in vivo., This work was supported by grants PID2019-111068GB-I00 (to A.M.) (AEI/FEDER, UE) and PID2019-105872GB-I00 (to J.M.V.) (AEI/FEDER, UE) from the Ministry of Science and Innovation and by the Basque Government (grant IT1201-19 to AM). The Centro Nacional de Biotecnología (CNB) is a Severo Ochoa Center of Excellence (MINECO award SEV 2017-0712)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Unzipping the Secrets of Amyloid Disassembly by the Human Disaggregase

  • Franco, Aitor
  • Velasco-Carneros, Lorea
  • Álvarez, Naiara
  • Orozco, Natalia
  • Moro, Fernando
  • Prado, Adelina
  • Muga, Arturo
Neurodegenerative diseases (NDs) are increasingly positioned as leading causes of global deaths. The accelerated aging of the population and its strong relationship with neurodegeneration forecast these pathologies as a huge global health problem in the upcoming years. In this scenario, there is an urgent need for understanding the basic molecular mechanisms associated with such diseases. A major molecular hallmark of most NDs is the accumulation of insoluble and toxic protein aggregates, known as amyloids, in extracellular or intracellular deposits. Here, we review the current knowledge on how molecular chaperones, and more specifically a ternary protein complex referred to as the human disaggregase, deals with amyloids. This machinery, composed of the constitutive Hsp70 (Hsc70), the class B J-protein DnaJB1 and the nucleotide exchange factor Apg2 (Hsp110), disassembles amyloids of α-synuclein implicated in Parkinson's disease as well as of other disease-associated proteins such as tau and huntingtin. We highlight recent studies that have led to the dissection of the mechanism used by this chaperone system to perform its disaggregase activity. We also discuss whether this chaperone-mediated disassembly mechanism could be used to solubilize other amyloidogenic substrates. Finally, we evaluate the implications of the chaperone system in amyloid clearance and associated toxicity, which could be critical for the development of new therapies., This research was funded by MCI/AEI/FEDER, UE (grant PID2019-111068GB-I00) and by the Basque Government (grant IT1201-19). L.V.-C. is the recipient of a predoctoral fellowship from the UPV/EHU and N.O. holds a contract funded by Fundacion Biofisika Bizkaia., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The self-association equilibrium of DNAJA2 regulates its interaction with unfolded substrate proteins and with Hsc70

  • Velasco-Carneros, Lorea
  • Cuéllar, Jorge
  • Dublang, Leire
  • Santiago, César
  • Maréchal, Jean Didier
  • Martín-Benito, Jaime
  • Maestro, Moisés
  • Fernández-Higuero, José Ángel
  • Orozco, Natalia
  • Moro, Fernando
  • Valpuesta, José M.
  • Muga, Arturo
J-domain proteins tune the specificity of Hsp70s, engaging them in precise functions. Despite their essential role, the structure and function of many J-domain proteins remain largely unknown. We explore human DNAJA2, finding that it reversibly forms highly-ordered, tubular structures that can be dissociated by Hsc70, the constitutively expressed Hsp70 isoform. Cryoelectron microscopy and mutational studies reveal that different domains are involved in self-association. Oligomer dissociation into dimers potentiates its interaction with unfolded client proteins. The J-domains are accessible to Hsc70 within the tubular structure. They allow binding of closely spaced Hsc70 molecules that could be transferred to the unfolded substrate for its cooperative remodelling, explaining the efficient recovery of DNAJA2-bound clients. The disordered C-terminal domain, comprising the last 52 residues, regulates its holding activity and productive interaction with Hsc70. These in vitro findings suggest that the association equilibrium of DNAJA2 could regulate its interaction with client proteins and Hsc70., This research was supported by grants PID2019-111068GB-I00 (AEI/FEDER, UE) to A.M., PID2020-117752RB-I00 (AEI/FEDER, UE) to J.M.B., and PID2019-105872GB-I00 and PID2022-137175NB-I00 (AEI/FEDER, UE) to J.M.V. and J.C., and by the Basque Government (grants IT1201-19 and IT1745-22 to F.M.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion

  • Santos, Jaime
  • Cuéllar, Jorge
  • Pallarès, Irantzu
  • Byrd, Emily J
  • Lends, Alons
  • Moro, Fernando
  • Abdul-Shukkoor, Muhammed Bilal
  • López-Pujol, Jordi
  • Velasco-Carneros, Lorea
  • Sobott, Frank
  • Otzen, Daniel E
  • Calabrese, Antonio N
  • Muga, Arturo
  • Pedersen, Jan Skov
  • Loquet, Antoine
  • Valpuesta, José M.
  • Radford, Sheena E
  • Ventura, Salvador
Oligomeric species populated during α-synuclein aggregation are considered key drivers of neurodegeneration in Parkinson's disease. However, the development of oligomer-targeting therapeutics is constrained by our limited knowledge of their structure and the molecular determinants driving their conversion to fibrils. Phenol-soluble modulin α3 (PSMα3) is a nanomolar peptide binder of α-synuclein oligomers that inhibits aggregation by blocking oligomer-to-fibril conversion. Here, we investigate the binding of PSMα3 to α-synuclein oligomers to discover the mechanistic basis of this protective activity. We find that PSMα3 selectively targets an α-synuclein N-terminal motif (residues 36-61) that populates a distinct conformation in the mono- and oligomeric states. This α-synuclein region plays a pivotal role in oligomer-to-fibril conversion as its absence renders the central NAC domain insufficient to prompt this structural transition. The hereditary mutation G51D, associated with early onset Parkinson's disease, causes a conformational fluctuation in this region, leading to delayed oligomer-to-fibril conversion and an accumulation of oligomers that are resistant to remodeling by molecular chaperones. Overall, our findings unveil a new targetable region in α-synuclein oligomers, advance our comprehension of oligomer-to-amyloid fibril conversion, and reveal a new facet of α-synuclein pathogenic mutations., The Spanish Ministry of Economy and Competitiveness (MINECO) grant BIO2017-91475-EXP (SV), the Spanish Ministry of Science and Innovation (MICINN) grants PID2019-105017RB-I00 (SV) and PID2022-137963OB-I00 (SV and IP), the MICINN grant PID2019-105872 GB-I00 (JMV) and PID2022-137175NB-I00 (JMV and JC), the MICINN grant PID2019-111068GB-I00 (AM) ICREA-Aca- demia 2015 (SV), the MICINN doctoral grant FPU17/01157 (JS), the Early postdoc mobility project SNSF P2EZP2_184258 (AL), the Basque Government grant IT1745-22 (FM), the BBSRC BB/M011151/1 grant (EJB), the Sir Henry Dale Fellowship jointly funded by Wellcome and the Royal Society 220628/Z/20/Z (ANC), the Royal Society grant RGS\R2\222357 (ANC), the University Academic Fellowship from the University of Leeds (ANC), and the Royal Society Research Professorship RSRP/R1/211057 (SER) are the funding sources., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pseudophosphorylation of single residues of the J-domain of DNAJA2 regulates the holding/folding balance of the Hsc70 system

  • Velasco-Carneros, Lorea
  • Bernardo-Seisdedos, Ganeko
  • Maréchal, Jean Didier
  • Millet, Óscar
  • Moro, Fernando
  • Muga, Arturo
The Hsp70 system is essential for maintaining protein homeostasis and comprises a central Hsp70 and two accessory proteins that belong to the J-domain protein (JDP) and nucleotide exchange factor families. Posttranslational modifications offer a means to tune the activity of the system. We explore how phosphorylation of specific residues of the J-domain of DNAJA2, a class A JDP, regulates Hsc70 activity using biochemical and structural approaches. Among these residues, we find that pseudophosphorylation of Y10 and S51 enhances the holding/folding balance of the Hsp70 system, reducing cochaperone collaboration with Hsc70 while maintaining the holding capacity. Truly phosphorylated J domains corroborate phosphomimetic variant effects. Notably, distinct mechanisms underlie functional impacts of these DNAJA2 variants. Pseudophosphorylation of Y10 induces partial disordering of the J domain, whereas the S51E substitution weakens essential DNAJA2-Hsc70 interactions without a large structural reorganization of the protein. S51 phosphorylation might be class-specific, as all cytosolic class A human JDPs harbor a phosphorylatable residue at this position., Basque Government, Grant/Award Number: IT1745-22; MICIU/AEI/10.13039/501100011033,Grant/Award Number: PID2019-111068GB-I00; Viceconsejería de Universidades e Investigación, Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion

  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Cuéllar, Jorge|||0000-0002-7789-807X
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Byrd, Emily|||0000-0002-9876-1400
  • Lends, Alons
  • Moro, Fernando
  • Abdul-Shukkoor, Muhammed Bilal
  • Pujols Pujol, Jordi|||0000-0001-9424-5866
  • Velasco-Carneros, Lorea|||0000-0002-1296-9498
  • Sobott, Frank|||0000-0001-9029-1865
  • Otzen, Daniel E.|||0000-0002-2918-8989
  • Calabrese, Antonio N.|||0000-0003-2437-7761
  • Muga, Arturo|||0000-0003-0345-6882
  • Pedersen, Jan Skov|||0000-0002-7768-0206
  • Loquet, Antoine|||0000-0001-7176-7813
  • Valpuesta, Jose María|||0000-0001-7468-8053
  • Radford, Sheena E.|||0000-0002-3079-8039
  • Ventura, Salvador|||0000-0002-9652-6351
Oligomeric species populated during α-synuclein aggregation are considered key drivers of neurodegeneration in Parkinson's disease. However, the development of oligomer-targeting therapeutics is constrained by our limited knowledge of their structure and the molecular determinants driving their conversion to fibrils. Phenol-soluble modulin α3 (PSMα3) is a nanomolar peptide binder of α-synuclein oligomers that inhibits aggregation by blocking oligomer-to-fibril conversion. Here, we investigate the binding of PSMα3 to α-synuclein oligomers to discover the mechanistic basis of this protective activity. We find that PSMα3 selectively targets an α-synuclein N-terminal motif (residues 36-61) that populates a distinct conformation in the mono- and oligomeric states. This α-synuclein region plays a pivotal role in oligomer-to-fibril conversion as its absence renders the central NAC domain insufficient to prompt this structural transition. The hereditary mutation G51D, associated with early onset Parkinson's disease, causes a conformational fluctuation in this region, leading to delayed oligomer-to-fibril conversion and an accumulation of oligomers that are resistant to remodeling by molecular chaperones. Overall, our findings unveil a new targetable region in α-synuclein oligomers, advance our comprehension of oligomer-to-amyloid fibril conversion, and reveal a new facet of α-synuclein pathogenic mutations.